Cultivators and Manufacturers Drive D.C. Medical Cannabis Market to Record $10.6M July
Washington, D.C.’s medical cannabis market set a revenue record in July 2026, reaching $10,605,830 in total program sales—a 20.0% year-over-year surge. While retail dispensaries held steady at $6.6M, upstream supply-chain operators drove the growth: manufacturers generated $3.09M and cultivation centers pulled in $903K. Resident patient registrations expanded to 136,882, while out-of-state visitors spending via self-certification temporary passes contributed over $2M in revenue. On the compliance front, regulatory enforcement activity paused following heavy closures in June, recording zero facility closures, zero violations, and zero waste destructions for the month.
- Subscribe to a paying membership to receive exclusive summaries of Board meetings and see our map of pending cannabis businesses in D.C.
- The ABC Board ‘s summer recess will end September 15.
AYR Wellness opens first medical cannabis dispensary in Virginia’s Area I
Multi-state operator AYR Wellness has officially launched the first medical cannabis dispensary serving Health Service Area I, filling a long-standing geographic gap for patients across the Shenandoah Valley and central Virginia. Situated just south of Winchester in Frederick County, the new facility expands local product access for registered patients across a 32-jurisdiction region who previously had to travel outside the health service area to purchase legal medical cannabis. In addition to retail operations, the site features a 5,000-square-foot cultivation space expected to harvest its first in-house flower early next year.
- The next CCA meeting is Sept. 9th, 2026. Catch up on the July 22nd CCA meeting here.
- The Cannabis Small Business Association is urging Virginia lawmakers to hold a dedicated public hearing on how the state’s newly enacted restrictions capping hemp products at 2 milligrams of total THC per package are threatening local businesses with financial ruin.
Baltimore cultivator Evermore fined $50,000, put on probation over ‘Employee Sample’ giveaway scheme
Maryland regulators have issued a two-year conditional probation and a $50,000 fine to Baltimore cultivator Evermore Cannabis Company following dozens of “employee sample” violations. A state audit of METRC seed-to-sale logs revealed 24 instances of staff receiving untested, unlabelled loose flower—sometimes up to 246 grams in a single transaction, well over legal possession limits—including six occasions where an inventory manager dispensed products to herself. Under the Consent Order, Evermore must pay the fine in monthly installments, submit quarterly audit reports, and institute mandatory staff retraining.
- The University of Maryland has issued a cease-and-desist letter to Colorado-based Terps USA, alleging that the company’s script logo and red-and-white color scheme improperly infringe on the school’s “TERPS” trademark.
ICYMI: D.C. ABCA Goes Fully Digital as Richmond Prepares for Community Signing Day
East Coast Roundup
Former Massachusetts Cannabis Control Commission Chair Shannon O’Brien has filed a lawsuit against state leadership alleging retaliation and invasion of privacy following her 2023 suspension and ultimate removal.
Ringleader Dwight Singletary pleaded guilty in federal court, marking the 25th and final conviction in a multi-state operation that shipped over 15,000 pounds of illicit cannabis from California to New York.
Culture & More
Escalating product potency across legal markets is driving higher rates of Cannabis Use Disorder, signaling a need for operators to prepare for stricter product warnings and public health guidance.
Rapidly climbing cannabis adoption among older adults is causing a surge in residential nuisance disputes, odor complaints, and HOA policy adjustments.
Gallup’s latest survey shows 17% of American adults now report smoking cannabis, surpassing cigarette usage (11%) as adult-use consumer preferences continue shifting toward plant-based alternatives.
Evolving consumer shopping habits and changing state regulatory frameworks are forcing multistate operators to rapidly adjust their inventory management and retail footprint strategies.
Systemic THC lab inflation continues to distort flower valuations, creating significant commercial risks for cultivators facing heightened regulatory scrutiny over inflated lab testing results.
A growing influx of American patients traveling to Mexican clinics for unregulated ibogaine therapy highlights commercial opportunities—and serious health risks—ahead of potential domestic psychedelic regulation.
Around the Country
Kentucky has reached a significant retail rollout milestone with 50% of its state-licensed medical dispensaries officially open to patients.
Alabama is expanding patient access as its second medical cannabis dispensary prepares to open its doors, with a third location nearing final state approval.
Alaskan cultivators continue to struggle under a rigid per-ounce flat excise tax as state legislators stall on passing reform legislation.
Chronic oversaturation, local tax burdens, and illegal competition are triggering widespread layoffs and operational downsizing among North Bay, California cannabis businesses.
Illinois health regulators have formally added endometriosis to the state’s list of qualifying conditions, expanding the potential medical patient base statewide.
From the Swamp
The DEA published the complete 2,533-page transcript from its 11-day administrative hearing as the presiding administrative law judge prepares his formal recommendation on moving cannabis to Schedule III.
Hemp-derived THC beverages are surging in mainstream retail outlets across the U.S., but the multi-million-dollar sector faces mounting legal jeopardy from impending federal loop-hole closures and state-level bans.
Newly published FBI crime statistics indicate that law enforcement agencies nationwide made over 200,000 arrests for simple cannabis possession in a single year despite expanding state-level legalization.
